Similar articles

• Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.

  Liberman L, Sama M, Susnik B, Rosen PP, LaTrenta LR, Morris EA, Abramson AF, Dershaw DD. Liberman L, et al. AJR Am J Roentgenol. 1999 Aug;173(2):291-9. doi: 10.2214/ajr.173.2.10430122. AJR Am J Roentgenol. 1999. PMID: 10430122
• [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].

  Piubello Q, Montemezzi S, D'Atri C. Piubello Q, et al. Pathologica. 2002 Dec;94(6):299-305. doi: 10.1007/s102420200053. Pathologica. 2002. PMID: 12540993 Italian.
• Current management of noninvasive (in situ) breast cancer.

  Silverstein MJ. Silverstein MJ. Adv Surg. 2000;34:17-41. Adv Surg. 2000. PMID: 10997214 Review. No abstract available.
• [Lobular carcinoma-in-situ and ductal hyperplasia of breast].

  Fu L. Fu L. Zhonghua Bing Li Xue Za Zhi. 2006 Jan;35(1):4-7. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 16608640 Chinese. No abstract available.
• Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why.

  Cohen MA. Cohen MA. Radiology. 2004 Jun;231(3):617-21. doi: 10.1148/radiol.2313040154. Radiology. 2004. PMID: 15163803 Review. No abstract available.